U-Neuron Biomedical (ROCO:6973) Common Stock: NT$395.50 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$33.70
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Common Stock?

U-Neuron Biomedical ROCO:6973 +1.81% 12 Common Stock is NT$395.50 Mil as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

U-Neuron Biomedical's quarterly common stock stayed the same from Dec. 2024 (NT$395.50 Mil) to Jun. 2025 (NT$395.50 Mil) and stayed the same from Jun. 2025 (NT$395.50 Mil) to Dec. 2025 (NT$395.50 Mil).

U-Neuron Biomedical's annual common stock increased from Dec. 2023 (NT$295.50 Mil) to Dec. 2024 (NT$395.50 Mil) but then stayed the same from Dec. 2024 (NT$395.50 Mil) to Dec. 2025 (NT$395.50 Mil).

U-Neuron Biomedical Common Stock Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Common Stock Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 150.00 155.50 295.50 395.50 395.50

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 295.50 295.50 395.50 395.50 395.50
ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$395.50 Mil mean?
U-Neuron Biomedical (ROCO:6973) has a Common Stock of NT$395.50 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's Common Stock too high?
U-Neuron Biomedical's current Common Stock is NT$395.50 Mil. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Common Stock compare to VRTX and REGN?
U-Neuron Biomedical's Common Stock of NT$395.50 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Common Stock is NT$395.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Common Stock of NT$395.50 Mil. The current Common Stock is NT$395.50 Mil. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Common Stock is NT$395.50 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.70
Price